IBRUTIX 140 MG
Product Description: Ibrutix (Ibrutinib) is a kinase inhibitor indicated for the treatment of patients with: Mantle Cell Lymphoma (MCL) who
IBRUXEN 140 MG
Ibruxen Capsule Ibrutinib 140 mg Everest Pharmaceuticals Ltd. Indications Mantle Cell Lymphoma: Ibrutinib is indicated for the treatment of patients with
LARONIB 25 MG
DESCRIPTION Laronib Larotrectinib 25 mg & 100 mg COMPOSITION LARONIB 25 capsules: Each capsule contains Larotrectinib Sulfate INN equivalent to
TOFACINIX 11 MG
Tofacinix Tablet (Extended Release) Tofacitinib 11 mg Beacon Pharmaceuticals Ltd. Indications Rheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult